The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Affiliation
University Hospitals Leuven (UZ Leuven) & KU Leuven
Country
Belgium
Current position
Prof. L. Van der Linden is currently active as a hospital pharmacist in UZ Leuven (Belgium). There, he mostly focuses on improving patient outcome by focusing on high-risk patient groups (ie, geriatric people) and certain drug therapies (ie, mostly cardiovascular therapies). He gives lectures on these topics to Master students from multiple Faculties, supervises PhD research and also provided clinical pharmacy services himself at the emergency department.
Education
Prof. Van der Linden is a licensed hospital pharmacist (2006), who also completed a post-graduate course on clinical pharmacy (2008). He obtained his PhD on the rational use of drug therapies in older adults in 2018. He currently is an appointed professor at KU Leuven (10%) and hospital pharmacist at UZ Leuven (90%).
Research area
The central theme of his research explores the causal relationship between medication use in high-risk adults, particularly within geriatric medicine and cardiology, and key clinical outcomes such as (re)hospitalizations. His work investigates how clinical pharmacists can drive improvements in these outcomes by optimizing medication use.
Conflict of interest
None